A Study to Evaluate the Safety, Tolerability, and Efficacy of BMS-986523 Alone and in Combination With Anti-Cancer Agents in Participants With Advanced Solid Malignancies
Bristol-Myers Squibb
Bristol-Myers Squibb
Genmab
Servier
Merck Sharp & Dohme LLC
PMV Pharmaceuticals, Inc
Mayo Clinic
Merck Sharp & Dohme LLC
NeoImmuneTech
Verastem, Inc.
Merck Sharp & Dohme LLC
Neonc Technologies, Inc.
Qurient Co., Ltd.
Essen Biotech
Nouscom SRL
Amsterdam UMC, location VUmc
Roswell Park Cancer Institute
National Institutes of Health Clinical Center (CC)
Takeda
Merck Sharp & Dohme LLC
Linnaeus Therapeutics, Inc.
Inhibrx Biosciences, Inc
VM Oncology, LLC
Curacell Holding AB
Yonsei University
Twinpig Biolab, Inc.
Tango Therapeutics, Inc.
Eisai Inc.
TriSalus Life Sciences, Inc.
Tvardi Therapeutics, Incorporated
Maastricht University Medical Center
Mirati Therapeutics Inc.
Eli Lilly and Company
BioInvent International AB
NuCana plc
Yonsei University
Medicenna Therapeutics, Inc.
University of Southern California
Medivir
Mayo Clinic
Triumvira Immunologics, Inc.
Rapa Therapeutics LLC
Aprea Therapeutics
TiumBio Co., Ltd.
Karyopharm Therapeutics Inc
MacroGenics
Imperial College London
Intensity Therapeutics, Inc.
Merus B.V.
NextCure, Inc.
Celularity Incorporated